Apogee Therapeutics
APGE
#4213
Rank
S$2.52 B
Marketcap
$43.49
Share price
-7.63%
Change (1 day)
-45.34%
Change (1 year)

Apogee Therapeutics (APGE) - Cash on Hand

Cash on Hand as of December 2024 : S$0.70 Billion

According to Apogee Therapeutics's latest financial reports the company has S$0.70 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Apogee Therapeutics - Cash on Hand chart (from 2022 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.70 B35.5%
2023-12-31S$0.52 B156.49%
2022-12-31S$0.20 B